Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C11H19N5.2ClH |
| Molecular Weight | 294.224 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.Cl.CC(C)C1=NC(N)=NC(=C1)N2CC[C@@H](N)C2
InChI
InChIKey=KXPWYAVIFCXPRW-YCBDHFTFSA-N
InChI=1S/C11H19N5.2ClH/c1-7(2)9-5-10(15-11(13)14-9)16-4-3-8(12)6-16;;/h5,7-8H,3-4,6,12H2,1-2H3,(H2,13,14,15);2*1H/t8-;;/m1../s1
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL3759 Sources: https://www.ncbi.nlm.nih.gov/pubmed/24495018 |
12.5 nM [Ki] |
PubMed
| Title | Date | PubMed |
|---|---|---|
| International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors. | 2015-07 |
|
| The histamine H₄ receptor antagonist, JNJ 39758979, is effective in reducing histamine-induced pruritus in a randomized clinical study in healthy subjects. | 2014-07 |
|
| Discovery and SAR of 6-alkyl-2,4-diaminopyrimidines as histamine H₄ receptor antagonists. | 2014-03-27 |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Code | English | ||
|
Preferred Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
W00RQD3LO2
Created by
admin on Wed Apr 02 12:05:49 GMT 2025 , Edited by admin on Wed Apr 02 12:05:49 GMT 2025
|
PRIMARY | |||
|
1620648-30-7
Created by
admin on Wed Apr 02 12:05:49 GMT 2025 , Edited by admin on Wed Apr 02 12:05:49 GMT 2025
|
NON-SPECIFIC STOICHIOMETRY | |||
|
129628806
Created by
admin on Wed Apr 02 12:05:49 GMT 2025 , Edited by admin on Wed Apr 02 12:05:49 GMT 2025
|
PRIMARY | |||
|
300000051570
Created by
admin on Wed Apr 02 12:05:49 GMT 2025 , Edited by admin on Wed Apr 02 12:05:49 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD